共 50 条
Switching from efavirenz/emtricitabine/tenofovir (EFV/FTC/TDF) or rilpivirine/emtricitabine/tenofovir disoproxil fumarate (RPV/FTC/TDF) to rilpivirine/emtricitabine/tenofovir alafenamide (RPV/FTC/TAF): safety and efficacy through 48 weeks
被引:0
作者:
Orkin, C.
[1
]
DeJesus, E.
[2
]
Ramgopal, M.
[3
]
Crofoot, G.
[4
]
Ruane, P.
[5
]
LaMarca, A.
[6
]
Mills, A.
[7
]
Van der Cam, B.
[8
]
De Wet, J.
[9
]
Rockstroh, J.
[10
]
Lazzarin, A.
[11
]
Rijnders, B.
[12
]
Podzamczer, D.
[13
]
Thalme, A.
[14
]
Stoeckle, M.
[15
]
Chu, H.
[16
]
Porter, D.
[16
]
Liu, H.
[16
]
Cheng, A.
[16
]
Quirk, E.
[16
]
SenGupta, D.
[16
]
Cao, H.
[16
]
机构:
[1] Barts Hlth NHS Trust, London, England
[2] Orlando Immunol Ctr, Orlando, FL USA
[3] Midway Immunol & Res Ctr, Ft Pierce, FL USA
[4] Crofoot Res Ctr, Houston, TX USA
[5] Peter Jerome Ruane, Los Angeles, CA USA
[6] Therafirst Med Ctr, Ft Lauderdale, FL USA
[7] Mills Clin Res, Los Angeles, CA USA
[8] Clin Univ St Luc, Brussels, Belgium
[9] JJ de Wet, Vancouver, BC, Canada
[10] Bonn Univ Hosp, Bonn, Germany
[11] Osped San Raffaele, Milan, Italy
[12] Erasmus MC, Rotterdam, Netherlands
[13] Hosp Univ Bellvitge, Barcelona, Spain
[14] Karolinska Univ Hosp, Stockholm, Sweden
[15] Univ Hosp Basel, Basel, Switzerland
[16] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
来源:
关键词:
D O I:
暂无
中图分类号:
R51 [传染病];
学科分类号:
100401 ;
摘要:
P20
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条